Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCS-01 for Inflammation and Pain Following Cataract Surgery (SKYGGN)
NCT04130802Phase 2Completed
- Sponsor
- Oculis
- Start
- Sep 2019
- Primary completion
- Jan 2020
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OCS-01 in post-operative ocular inflammation, post-operative ocular pain, sponsored by Oculis. Started Sep 2019; status: completed.
02
Drugs
OCS-01
03
Conditions
post-operative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on NCT04130802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04130802.